Bank Of America Corp Altimmune, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Altimmune, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 280,552 shares of ALT stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

280,552

Previous 181,889 54.24%

Holding current value

$1.58 Million

Previous $1.31 Million 6.94%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$5.0 - $7.45 $493,315 - $735,039	98,663 Added 54.24%	280,552 $1.4 Million
Q4 2024 Feb 14, 2025	BUY	$6.02 - $9.85 $194,939 - $318,962	32,382 Added 21.66%	181,889 $1.31 Million
Q3 2024 Nov 14, 2024	SELL	$5.5 - $8.1 $714,070 - $1.05 Million	-129,831 Reduced 46.48%	149,507 $917,000
Q2 2024 Aug 14, 2024	SELL	$5.91 - $10.23 $1.3 Million - $2.26 Million	-220,534 Reduced 44.12%	279,338 $1.86 Million
Q1 2024 May 15, 2024	BUY	$8.22 - $13.81 $3.89 Million - $6.53 Million	472,895 Added 1752.96%	499,872 $5.09 Million
Q4 2023 Feb 14, 2024	SELL	$2.14 - $11.62 $117,049 - $635,567	-54,696 Reduced 66.97%	26,977 $303,000
Q2 2023 Aug 14, 2023	SELL	$3.45 - $5.97 $1.95 Million - $3.37 Million	-564,473 Reduced 87.36%	81,673 $288,000
Q1 2023 May 12, 2023	BUY	$4.19 - $16.83 $488,176 - $1.96 Million	116,510 Added 22.0%	646,146 $2.73 Million
Q4 2022 Feb 10, 2023	BUY	$8.74 - $16.45 $2.34 Million - $4.4 Million	267,432 Added 101.99%	529,636 $8.71 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $2.1 Million - $4.42 Million	197,231 Added 303.56%	262,204 $3.35 Million
Q2 2022 Aug 12, 2022	BUY	$3.94 - $11.77 $166,011 - $495,928	42,135 Added 184.5%	64,973 $760,000
Q1 2022 May 16, 2022	SELL	$5.9 - $9.45 $1.2 Million - $1.92 Million	-202,732 Reduced 89.88%	22,838 $140,000
Q4 2021 Feb 08, 2022	BUY	$8.69 - $12.48 $1.77 Million - $2.55 Million	204,148 Added 952.98%	225,570 $2.07 Million
Q3 2021 Nov 15, 2021	BUY	$8.43 - $16.81 $25,500 - $50,850	3,025 Added 16.44%	21,422 $243,000
Q2 2021 Sep 13, 2021	BUY	$9.85 - $16.46 $181,210 - $302,814	18,397 New	18,397 $181,000

Others Institutions Holding ALT

# of Institutions

203

Shares Held

37.6M

Call Options Held

Put Options Held

1.69M

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $276M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Altimmune, Inc. Transaction History